Publication | Closed Access

111Indium-trastuzumab visualises myocardial human epidermal growth factor receptor 2 expression shortly after anthracycline treatment but not during heart failure: A clue to uncover the mechanisms of trastuzumab-related cardiotoxicity

InflammationTrastuzumab-related CardiotoxicityHeart FailureCardiomyopathyStructural Heart DiseaseCardiovascular DiseaseImmunologyPathologyAnthracycline TreatmentCardiovascular ToxicityMedicineCardiologyTumor Microenvironment